Home/180 Life Sciences/Dr. James N. Woody
DJ

Dr. James N. Woody

Chief Executive Officer & Director

180 Life Sciences

180 Life Sciences Pipeline

DrugIndicationPhase
Anti-TNF (Local Administration)Dupuytren's Disease (Early Stage)Phase 2b
Synthetic Cannabinoid AnalogsChronic Pain & InflammationPre-clinical
α7nAChR ProgramInflammatory Bowel Disease (IBD) & Other Inflammatory ConditionsPre-clinical